Latest filings (excl ownership)
D
$24.13 mm in equity / options, sold $24.13 mm, 185 investors
17 Apr 24
10-K
2023 FY
Annual report
16 Apr 24
8-K
Movano Health Reports 2023 Financial Results and Provides Business Update
4 Apr 24
8-K
Entry into a Material Definitive Agreement
3 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement
29 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Nov 23
424B5
Prospectus supplement for primary offering
16 Nov 23
8-K
Movano Health Announces Proposed Public Offering
15 Nov 23
8-K
Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results
15 Nov 23
424B5
Prospectus supplement for primary offering
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Movano Health Provides Business Update and Reports Second Quarter 2023 Financial Results
14 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
21 Jun 23
424B5
Prospectus supplement for primary offering
13 Jun 23
8-K
Movano Health Announces Proposed Public Offering
13 Jun 23
424B5
Prospectus supplement for primary offering
12 Jun 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Movano Health Provides Business Update and Reports First Quarter 2023 Financial Results
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
17 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results
20 Mar 23
8-K
Movano Health Announces Proposed Public Offering
31 Jan 23
424B5
Prospectus supplement for primary offering
31 Jan 23
424B5
Prospectus supplement for primary offering
26 Jan 23
8-K
Movano Health Provides Business Update and Reports Third Quarter 2022 Financial Results
14 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
Movano Inc. Provides Business Update and Reports Second Quarter 2022 Financial Results
15 Aug 22
S-8
Registration of securities for employees
15 Aug 22
424B5
Prospectus supplement for primary offering
15 Aug 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
8-K
Departure of Directors or Certain Officers
22 Jun 22
EFFECT
Notice of effectiveness
26 May 22
CORRESP
Correspondence with SEC
24 May 22
S-3/A
Shelf registration (amended)
19 May 22
10-Q
2022 Q1
Quarterly report
12 May 22
Latest ownership filings
4
Ruben Caballero
12 Apr 24
SC 13G
APPEL PETER A
10 Apr 24
SC 13G/A
Tamkin Gregory S
9 Apr 24
4
Jeremy Cogan
4 Apr 24
4
Brian Cullinan
4 Apr 24
4
EMILY FAIRBAIRN
4 Apr 24
4
John Mastrototaro
4 Apr 24
4
Nan Kirsten Forte
4 Jan 24
4
EMILY FAIRBAIRN
4 Jan 24
4
Brian Cullinan
4 Jan 24
4
Ruben Caballero
4 Jan 24
4
EMILY FAIRBAIRN
15 Nov 23
4
John Mastrototaro
15 Nov 23
4
Jeremy Cogan
15 Nov 23
4
Jeremy Cogan
15 Jun 23
4
Michael Aaron Leabman
15 Jun 23
4
John Mastrototaro
15 Jun 23
4
EMILY FAIRBAIRN
15 Jun 23
4
Brian Cullinan
15 Jun 23
4
Michael Aaron Leabman
23 Mar 23
4
John Mastrototaro
23 Mar 23
4
Jeremy Cogan
23 Mar 23
4
Ruben Caballero
23 Mar 23
4
Brian Cullinan
23 Mar 23
4
EMILY FAIRBAIRN
23 Mar 23
4
Nan Kirsten Forte
23 Mar 23
4
Ruben Caballero
16 Feb 23
4
Jeremy Cogan
30 Jan 23
4
Nan Kirsten Forte
30 Jan 23
4
Brian Cullinan
30 Jan 23
4
EMILY FAIRBAIRN
30 Jan 23
4
Michael Aaron Leabman
30 Jan 23
4
John Mastrototaro
30 Jan 23
4
John Mastrototaro
16 May 22
4
Nan Kirsten Forte
19 Apr 22
3
Nan Kirsten Forte
19 Apr 22
4
EMILY FAIRBAIRN
4 Apr 22
SC 13G
Ho William Tai-Wei
4 Feb 22
SC 13G
Tamkin Gregory S
4 Feb 22
4
Brian Cullinan
5 Jan 22